PeptideStack
5.2kquestions
20kanswers
220users

Why did my creatinine move after two weeks on ecnoglutide?

Asked 29 May 2026Modified 21 days agoViewed 7.9k times
20

Setup, so nobody has to ask: creatinine · two weeks · ecnoglutide.

This is not behaving the way I expected and I want to understand the discrepancy before I act on it.

I have photographed the current state and recorded the conditions, so I can answer follow-up questions precisely.

How do I distinguish the benign explanation from the one that matters?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
ecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

223 questions
shareeditfollowflag
HV
askedh_villanueva70k4829 May 2026
4Same laboratory as last time? Between-laboratory differences are larger than most of the changes people chase. – coldpack_88 11 days ago
8Can you say how far out of range rather than that it was flagged? The flag is a threshold, not a finding. – meniscus_film 9 months ago
add a comment

5 Answers

Accepted answer first, then by votes
-2

Accepted answer

2 weeks is 14 days, and the first question about any marker is whether 14 days is long enough for it to have finished moving. Creatinine is produced from muscle at a rate proportional to how much of it there is, so a falling creatinine during weight loss is a body-composition result before it is a renal one. Against 14 days the marker is at or near the edge of its own settling time, so part of what you are reading is the transition rather than the destination. The second question is the denominator. Weight loss moves plasma volume, muscle mass and intake at once, and several of the markers on a routine panel are ratios with one of those three underneath them. Repeat before interpreting. A single value 14 days in, with no baseline drawn under the same conditions, is a number rather than a change — and nothing here is medical advice.

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

Decide the action for each result before you order the test.

shareimprove this answerflag
CO
answered · acceptedcoldbox941k13827 Jun 2026
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
26

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Pre-analytical factors — posture, tourniquet time, fasting, sample handling — are the largest source of error in routine biochemistry, well ahead of the analysis itself.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
HP
answeredh_pergande71k15822 Jun 2026
21

This is answerable, and the answer is mostly about which tests rather than how many.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

Specifically, a sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Nothing here is medical advice. If something is out of range and you do not know why, that is a consultation rather than a research project.

Keep the full report, not the number. You will need the units and the interval later.

shareimprove this answerflag
DA
answeredDr_Rosalind_Achebe69k14717 Jun 2026
16

Answer first: decide what you would do differently for each possible result before you order the panel. Anything that fails that test is a number you will worry about and not act on.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

edited 9 Jul 2026 by Dr_Colm_Fitzhenry — corrected a unit error in the worked example

shareimprove this answerflag
DF
answeredDr_Colm_Fitzhenry69k24712 Jun 2026
7This should be linked from the help pages. – bufferline42 21 days ago
add a comment
12

Answering this needs to distinguish screening from monitoring. A screening panel looks for the unexpected; a monitoring panel tracks something you already have a reason to watch.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Research-use compounds are not approved for human use, and no panel makes that safer.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

edited 8 Jun 2026 by coldbox9 — expanded the table to cover the lower concentration

shareimprove this answerflag
CO
answeredcoldbox941k1387 Jun 2026
5I would add a sentence about baseline: without one, the second panel is a snapshot rather than a trend. – Dr_Rosalind_Achebe 8 months ago
4Is the assay method stated on your report? Two immunoassays for the same analyte do not agree with each other. – bea_castellanos 6 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.